A carregar...
Clinical consequences of the presence of anti-RNA Pol III antibodies in systemic sclerosis
INTRODUCTION: Anti-RNA polymerase III (a-RNA Pol III) antibodies are marker antibodies in patients with systemic sclerosis (SSc). AIM: To assess the prevalence of a-RNA Pol III in patients with SSc and to identify the differences in the disease picture in SSc patients with and without a-RNA Pol III...
Na minha lista:
| Publicado no: | Postepy Dermatol Alergol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Termedia Publishing House
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7874867/ https://ncbi.nlm.nih.gov/pubmed/33603608 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ada.2020.102107 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|